Autologous CD7 CAR T-cell
BJGBYY-IIT-LCYJ-2024-003
Phase 2 small_molecule active
Quick answer
Autologous CD7 CAR T-cell for T-cell Acute Lymphoblastic Leukemia is a Phase 2 program (small_molecule) at INTEGRATED BIOPHARMA INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- INTEGRATED BIOPHARMA INC
- Indication
- T-cell Acute Lymphoblastic Leukemia
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active